These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Safety and antigenicity of temperature sensitive (TS) mutant respiratory syncytial virus (RSV) in infants and children. Kim HW; Arrobio JO; Brandt CD; Wright P; Hodes D; Chanock RM; Parrott RH Pediatrics; 1973 Jul; 52(1):56-63. PubMed ID: 4353352 [No Abstract] [Full Text] [Related]
3. Respiratory syncytial virus in infants and children. Parrott RH; Kim HW; Brandt CD; Chanock RM Prev Med; 1974 Dec; 3(4):473-80. PubMed ID: 4373702 [No Abstract] [Full Text] [Related]
4. Reliability of the serological method of examination as a basis for diagnosis of associated respiratory virus infections. Mayorova LP; Mikutskaya BA; Morozenko MA; Sokolova LA; Boldasov VK J Hyg Epidemiol Microbiol Immunol; 1976; 21(3):314-31. PubMed ID: 188945 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of five temperature-sensitive mutants of respiratory syncytial virus in primates: I. Viral shedding, immunologic response, and associated illness. Richardson LS; Belshe RB; London WT; Sly DL; Prevar DA; Camargo E; Chanock RM J Med Virol; 1978; 3(2):91-100. PubMed ID: 104004 [No Abstract] [Full Text] [Related]
6. The role of the secretory immune system in protection against agents which infect the respiratory tract. Waldman RH; Ganguly R Adv Exp Med Biol; 1974; 45(0):283-94. PubMed ID: 4370501 [No Abstract] [Full Text] [Related]
7. Phase-I study MEDI-534, of a live, attenuated intranasal vaccine against respiratory syncytial virus and parainfluenza-3 virus in seropositive children. Gomez M; Mufson MA; Dubovsky F; Knightly C; Zeng W; Losonsky G Pediatr Infect Dis J; 2009 Jul; 28(7):655-8. PubMed ID: 19483659 [TBL] [Abstract][Full Text] [Related]
9. Respiratory virus vaccines. V. Field evaluation for efficacy of heptavalent vaccine. Weibel RE; Stokes J; Leagus MB; Mascoli CC; Hilleman MR Am Rev Respir Dis; 1966 Sep; 94(3):362-79. PubMed ID: 4288226 [No Abstract] [Full Text] [Related]
10. Respiratory syncytial virus infection in owl monkeys: viral shedding, immunological response, and associated illness caused by wild-type virus and two temperature-sensitive mutants. Prince GA; Suffin SC; Prevar DA; Camargo E; Sly DL; London WT; Chanock RM Infect Immun; 1979 Dec; 26(3):1009-13. PubMed ID: 118925 [TBL] [Abstract][Full Text] [Related]
11. Potential of attenuated respiratory syncytial virus vaccine for infants and children. Parrott RH; Kim HW; Brandt CD; Chanock RM Dev Biol Stand; 1975; 28():389-99. PubMed ID: 165119 [TBL] [Abstract][Full Text] [Related]
12. [Comparative value of the immunofluorescence method and serologic methods in the diagnosis of respiratory-syncytial virus infections in children]. Dreĭzin RS; Korzhenkova MP; Ponomareva TI Vopr Virusol; 1968; 13(6):704-8. PubMed ID: 4892409 [No Abstract] [Full Text] [Related]
14. Non-specific Effects of Live Attenuated Pertussis Vaccine Against Heterologous Infectious and Inflammatory Diseases. Cauchi S; Locht C Front Immunol; 2018; 9():2872. PubMed ID: 30581436 [No Abstract] [Full Text] [Related]
15. Determinants of susceptibility to challenge and the antibody response of adult volunteers given experimental respiratory syncytial virus vaccines. Watt PJ; Robinson BS; Pringle CR; Tyrrell DA Vaccine; 1990 Jun; 8(3):231-6. PubMed ID: 2363300 [TBL] [Abstract][Full Text] [Related]